Toll Free: 1-888-928-9744
Published: Jul, 2015 | Pages:
40 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
AmpliPhi Biosciences Corporation - Product Pipeline Review - 2015 Summary Global Markets Direct's, 'AmpliPhi Biosciences Corporation - Product Pipeline Review - 2015', provides an overview of the AmpliPhi Biosciences Corporation's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of AmpliPhi Biosciences Corporation's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of AmpliPhi Biosciences Corporation including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of AmpliPhi Biosciences Corporation's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the AmpliPhi Biosciences Corporation's pipeline products Reasons to buy - Evaluate AmpliPhi Biosciences Corporation's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of AmpliPhi Biosciences Corporation in its therapy areas of focus - Identify new drug targets and therapeutic classes in the AmpliPhi Biosciences Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of AmpliPhi Biosciences Corporation and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of AmpliPhi Biosciences Corporation - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope - Explore the dormant and discontinued projects of AmpliPhi Biosciences Corporation and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 AmpliPhi Biosciences Corporation Snapshot 5 AmpliPhi Biosciences Corporation Overview 5 Key Information 5 Key Facts 5 AmpliPhi Biosciences Corporation - Research and Development Overview 6 Key Therapeutic Areas 6 AmpliPhi Biosciences Corporation - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Out-Licensed Products 10 Out-Licensed Products/Combination Treatment Modalities 11 AmpliPhi Biosciences Corporation - Pipeline Products Glance 12 AmpliPhi Biosciences Corporation - Clinical Stage Pipeline Products 12 Phase I Products/Combination Treatment Modalities 12 AmpliPhi Biosciences Corporation - Early Stage Pipeline Products 13 Preclinical Products/Combination Treatment Modalities 13 Discovery Products/Combination Treatment Modalities 14 AmpliPhi Biosciences Corporation - Drug Profiles 15 tgAAG-76 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 AmpliPHAGE-001 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 AmpliPhage-002 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 AmpliPHAGE-004 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 AmpliPHAGE-001 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 AmpliPhage-002 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 AmpliPHAGE-004 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Biologics for Acinetobacter Baumanii 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 Biologics for Acinetobacter Baumanii 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 AmpliPhi Biosciences Corporation - Pipeline Analysis 27 AmpliPhi Biosciences Corporation - Pipeline Products by Target 27 AmpliPhi Biosciences Corporation - Pipeline Products by Route of Administration 28 AmpliPhi Biosciences Corporation - Pipeline Products by Molecule Type 29 AmpliPhi Biosciences Corporation - Pipeline Products by Mechanism of Action 30 AmpliPhi Biosciences Corporation - Recent Pipeline Updates 31 AmpliPhi Biosciences Corporation - Dormant Projects 33 AmpliPhi Biosciences Corporation - Discontinued Pipeline Products 34 Discontinued Pipeline Product Profiles 34 tg-AAVCF 34 AmpliPhi Biosciences Corporation - Company Statement 35 AmpliPhi Biosciences Corporation - Locations And Subsidiaries 38 Head Office 38 Other Locations & Subsidiaries 38 Appendix 39 Methodology 39 Coverage 39 Secondary Research 39 Primary Research 39 Expert Panel Validation 39 Contact Us 39 Disclaimer 40
List of Tables
AmpliPhi Biosciences Corporation, Key Information 5 AmpliPhi Biosciences Corporation, Key Facts 5 AmpliPhi Biosciences Corporation - Pipeline by Indication, 2015 7 AmpliPhi Biosciences Corporation - Pipeline by Stage of Development, 2015 8 AmpliPhi Biosciences Corporation - Monotherapy Products in Pipeline, 2015 9 AmpliPhi Biosciences Corporation - Out-Licensed Products in Pipeline, 2015 10 AmpliPhi Biosciences Corporation - Out-Licensed Products/ Combination Treatment Modalities, 2015 11 AmpliPhi Biosciences Corporation - Phase I, 2015 12 AmpliPhi Biosciences Corporation - Preclinical, 2015 13 AmpliPhi Biosciences Corporation - Discovery, 2015 14 AmpliPhi Biosciences Corporation - Pipeline by Target, 2015 27 AmpliPhi Biosciences Corporation - Pipeline by Route of Administration, 2015 28 AmpliPhi Biosciences Corporation - Pipeline by Molecule Type, 2015 29 AmpliPhi Biosciences Corporation - Pipeline Products by Mechanism of Action, 2015 30 AmpliPhi Biosciences Corporation - Recent Pipeline Updates, 2015 31 AmpliPhi Biosciences Corporation - Dormant Developmental Projects,2015 33 AmpliPhi Biosciences Corporation - Discontinued Pipeline Products, 2015 34 AmpliPhi Biosciences Corporation, Other Locations 38 AmpliPhi Biosciences Corporation, Subsidiaries 38
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.